Skip to content

Public FDA record

Z-2169-2017: AIA-PACK TgAb CONTROL SET

Recall record Z-2169-2017 for Tosoh Bioscience, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2169-2017
Company in FDA record
Tosoh Bioscience, Inc.
FDA classification date
May 15, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

The label contains two different methodologies. Quality Control values for non-FDA approved methodology (CL) are on the label in addition to the FDA approved methodology values (AIA). Two sets of instructions were included on the label.

Source facts

Action
On 3/3/2017 the firm sent recall notificaion letters to their customers.
Initiated
2017-02-08
Root cause
Labeling mix-ups
Terminated
2019-02-08
Distribution
Product was shipped to the following states: AK, FL, GA, MA, NY, NY, OH, OK & TX.
Recall number
Z-2169-2017
Recall status
Terminated
CDRH record ID
154073
FDA classified
2017-05-15
Recall event number
76659

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗